in a five-year follow-up of a randomized clinical trial, psilocybin-assisted therapy was associated with lasting reductions in depression symptoms in adults with major depressive disorder (MDD).

A narrative review in Brain Sciences evaluated 29 studies and found evidence that psilocybin could play a role in recovery after traumatic brain injury (TBI).